Tech Company Financing Transactions

Intradigm Funding Round

Alta Partners, Frazier Healthcare Partners and Emerging Technology Partners joined a $16 million Series A funding round for Intradigm. The round was announced on 11/21/2006.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

21 Albemarle Street
London, W1S 4BS
UK

Phone

+44 (0) 20 7491 6520

Website

www.intradigm.com

Email Address

[email protected]

Overview

Our Mission: To deliver the promise of RNA interference (RNAi) therapeutics for the treatment of human diseases with unmet medical needs through our advanced targeted systemic delivery technology with an initial focus on oncology therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Thomas Christély

        

Chief Financial Officer

Max Herrmann

        

Chief Scientific Officer

Klaus Giese

        

VP - Bus. Development

Tony Sedgwick

        

VP - R & D

Jorg Kaufmann

        

Browse more venture capital transactions:

Prev: 11/20/2006: Newport Media venture capital transaction
Next: 11/21/2006: Intechra venture capital transaction

Share this article

News on VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary